Description

Ambrotard (Ambroxol) Capsules with Prolonged Release 75 mg. №10

Composition

Each capsule contains 75 mg of ambroxol.

Mechanism of Action

Pharmacological Properties: Ambroxol increases the production of pulmonary surfactant, aiding in airway lubrication and mucus clearance. It also exhibits antioxidant effects, reducing inflammation in the respiratory tract.

Indications for Use

Detailed Indications: Ambrotard capsules are indicated for treating respiratory conditions characterized by excessive mucus production. They facilitate mucus loosening and clearance in the airways, easing expectoration.

Contraindications

Contraindications: Avoid Ambrotard capsules if allergic to ambroxol or any other components. Consult a healthcare provider before use during pregnancy, lactation, or with underlying medical conditions.

Side Effects

Common side effects may include gastrointestinal disturbances, such as nausea or diarrhea. If any adverse reactions occur, discontinue use and seek medical advice.

Usage Instructions

Dosage and Administration: Take one capsule orally with a full glass of water daily, preferably with food. Swallow the capsule whole without crushing or chewing for optimal efficacy.

Benefits Compared to Analogues

Ambrotard capsules with prolonged release offer sustained symptom relief throughout the day, ensuring continuous respiratory support. The extended release formulation provides convenience and effectiveness compared to immediate-release alternatives.

Suitable Patient Groups

Ambrotard is suitable for adults, including the elderly, and adolescents for the management of respiratory conditions involving excessive mucus secretion. Use in children should be under medical supervision.

Storage and Shelf Life

Store Ambrotard capsules in a cool, dry place away from direct sunlight. Keep out of reach of children. Check the expiration date on the packaging and do not use expired products.

Packaging Description

The product comes in a pack containing 10 capsules of 75 mg each with prolonged release formulation. The packaging is designed to maintain product integrity and ensure dosage accuracy.

Clinical Evidence and Proven Effectiveness

Ambroxol, the active ingredient in Ambrotard, has demonstrated mucolytic and expectorant properties in numerous studies. Clinical trials have shown improved mucus clearance and reduced cough frequency in respiratory patients. Notably, a study in the International Journal of Chronic Obstructive Pulmonary Disease highlighted enhanced lung function and reduced exacerbations in chronic bronchitis patients.

Additionally, a randomized controlled trial in the Journal of Pulmonary Medicine compared ambroxol to standard therapy for acute exacerbations of chronic bronchitis. The results indicated significant improvements in cough clearance and lung function with ambroxol treatment.